Heidi Splete October 06, 2023TOPLINE:Matched cohort studies revealed infrequent adverse events (AEs) with either treatment, but the number needed to harm for any AE was more than three times higher with colchicine vs NSAIDs. METHODOLOGY:The researchers conducted two matched retrospective cohort studies using the UK Clinical Practice Research Datalink and the Hospital Episode Statistics primary...
Tag: <span>Colchicine</span>
Post
A sharp increase in the price of gout drug colchicine led to lower use and poorer disease control, research suggests
by University of California, Los AngelesCredit: Pixabay/CC0 Public Domain Due to a policy decision in 2010 by the U.S. Food and Drug Administration (FDA), the price of a prescription for the therapeutic gout drug colchicine increased nearly 16-fold from $11.25 in 2009 to $190.49 in 2011. Out-of-pocket costs for patients who took the drug jumped more...
Post
Colchicine may have therapeutic potential against COVID-19
By Dr. Liji Thomas, MD Feb 1 2021 Against the sheer scale of morbidity and death due to the ongoing coronavirus disease 2019 (COVID-19) pandemic, the urgency of identifying drugs and other measures that reduce these adverse outcomes is enormous. A new study – involving an international team of researchers from Canada, the U.S. and Brazil –...
Post
Could Colchicine Be the New Aspirin?
Jean-Claude Tardif, MD; Michel Zeitouni, MD, MSc DISCLOSURES January 27, 2020 This interview is a translation of a video discussion posted on Medscape France. It has been edited for clarity. Michel Zeitouni, MD, MSc: Hello. I am Michel Zeitouni, a cardiologist at the Pitié-Salpêtrière Hospital and a researcher with the organization ACTION Cœur (Allies in...